Fludarabine, mitoxantrone and dexametasone in the treatment of relapsed and refractory low-grade non-Hodgkin lymphoma.

被引：0
|
作者：
Sawczuk-Chabin, J
Kalinka, E
Centkowski, P
Budziszewska, K
Ceglarek, B
Najda, J
Blasinska-Morawiec, M
Sulek, K
Holowiecki, J
Konopka, L
Warzocha, K
机构：
[1] Inst Hematol & Blood Transfus, Dept Hematol, Warsaw, Poland
[2] Reg Canc Ctr, Dept Proliferat Dis, Lodz, Poland
[3] Mil Inst Med, Dept Hematol, Warsaw, Poland
[4] Inst Hematol & Blood Transfus, Dept Hematol & Internal Med, Warsaw, Poland
[5] L Warynski Silesian Med Acad, Dept Hematol, Katowice, Poland
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
10.1182/blood.V106.11.4738.4738
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
4738
引用
收藏
页码：265B / 265B
页数：1
相关论文
共 50 条
  • [1] Fludarabine in combination with cyclophosphamide or with cyclophosphamide plus mitoxantrone for relapsed or refractory low-grade non-Hodgkin's lymphoma
    Santini, G
    Nati, S
    Spriano, M
    Gallamini, A
    Pierluigi, D
    Congiu, AM
    Truini, M
    Rubagotti, A
    Chisesi, T
    Vimercati, R
    Rossi, E
    Sertoli, MR
    Mattei, D
    Marino, G
    Gobbi, M
    HAEMATOLOGICA, 2001, 86 (03) : 282 - 286
  • [2] Fludarabine, mitoxantrone and dexamethasone in the treatment of relapsed and refractory lowgrade non-Hodgkin lymphoma
    Sawczuk-Chabin, J
    Kalinka, E
    Centkowski, P
    Budziszewska, K
    Ceglarek, B
    Najda, J
    Blasinska-Morawiec, M
    Sulek, K
    Holowiecki, J
    Konopka, L
    Warzocha, K
    ANNALS OF ONCOLOGY, 2005, 16 : 151 - 151
  • [3] Fludarabine, cyclophosphamide and mitoxantrone in relapsed or refractory chronic lymphocytic leukemia and low grade non-Hodgkin's lymphoma
    Hendry, L
    Bowen, A
    Matutes, E
    Swansbury, J
    Catovsky, D
    LEUKEMIA & LYMPHOMA, 2004, 45 (05) : 945 - 950
  • [4] Rituximab in the treatment of patients with relapsed low-grade or follicular non-Hodgkin's lymphoma.
    Capote, FJ
    Bernabé, R
    Martin, MV
    Porta, J
    Almagro, M
    Moreno-Nogueira, JA
    Gil, JL
    EUROPEAN JOURNAL OF CANCER, 1999, 35 : S90 - S90
  • [5] Fludarabine, Cyclophosphamide and Dexamethasone (FLUCYD) for the treatment of advanced low-grade non-Hodgkin's lymphoma.
    Lazzarino, M
    Orlandi, E
    Montillo, M
    Tedeschi, A
    Pagnucco, G
    Astori, C
    Crugnola, M
    Gargantini, L
    Corso, A
    Brusamolino, E
    Morra, E
    Bernasconi, C
    BLOOD, 1997, 90 (10) : 1533 - 1533
  • [6] Phase II study of fludarabine and cyclophosphamide in the treatment of relapsed low grade non-Hodgkin's lymphoma.
    Lucie, NP
    Dunlop, DJ
    Soukop, M
    McKay, PJ
    Stark, AN
    Anderson, SM
    Paul, J
    BLOOD, 2001, 98 (11) : 606A - 607A
  • [7] Phase II trial of Doxil® in patients with refractory/relapsed low-grade non-Hodgkin's lymphoma.
    Di Bella, NJ
    Khan, MM
    Dakhil, SR
    Logie, KW
    Marsland, TA
    Simon, SR
    Weinstein, RE
    BLOOD, 2000, 96 (11) : 236B - 236B
  • [8] Fludarabine and cladribine in relapsed/refractory low-grade non-Hodgkin's lymphoma: A phase II randomized study
    Tondini, C
    Balzarotti, M
    Rampinelli, I
    Valagussa, P
    Luoni, M
    De Paoli, A
    Santoro, A
    Bonadonna, G
    ANNALS OF ONCOLOGY, 2000, 11 (02) : 231 - 233
  • [9] Fludarabine (FLU) in combination: An effective therapy for relapsed or refractory low-grade non-Hodgkin's lymphoma (LGL)
    Santini, G
    Nati, S
    Spriano, M
    Congiu, AM
    Marino, G
    Rossi, E
    Vimercati, R
    Pierluigi, D
    Clavio, M
    Gobbi, M
    Damasio, E
    EXPERIMENTAL HEMATOLOGY, 1999, 27 (07) : 80 - 80
  • [10] Chemoimmunotherapy with Fludarabine, Bendamustine and Rituximab for relapsed low grade malignant Non-Hodgkin's Lymphoma.
    Kirchner, HH
    Gaede, B
    Steinhauer, EU
    Panagiotou, P
    Sosada, M
    BLOOD, 2001, 98 (11) : 135A - 135A
12345